*Efficacy of transforaminal hyaluronidase versus transforaminal ozone in herniated lumbar disc pai

Phase 3

• Conditions: lumbar radicular pain.; Lumbosacral plexus disorders; G54.1

• Registration Number: IRCT20181011041308N3
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Radicular lumbar pain for more than 6 months
Disc protrusion
One or two levels are involved
No response to conservative therapy for 3 months
Pain score more than 3

Exclusion Criteria

Patient,s discontent
ASA more than 2
Spine deformity
Vertebral listhesis ,grade 2 or more
Lumbar spine surgery
Anti coagulation therapy
Drug and alcohol abuse
Drug allergic reactions
Local or systemic infection
Pregnancy
MRI contraindications
Severe pulmonary disease
Severe psychiatric disease
Peripheral neuropathy
Spine fracture

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual Analog Scale. Timepoint: 2 weeks-1 month- 2 months-3 months. Method of measurement: asking from patient.;Oswestry Disability Index. Timepoint: 2 weeks-1 month-2 months -3 months. Method of measurement: asking from patient.;Consumed- drugs. Timepoint: 2 weeks-1 month-2 months -3 months. Method of measurement: asking from patient.